Pre-clinical evaluation of TYK2 inhibitors for human beta cell protection in type 1 diabetes. Coomans de Brachene A, Castela A, Op de Beeck A, Mirmira RG, et al. Diabetes Obes Metab 2020 Jun 1. doi: 10.1111/dom.14104.

Read + Share

Amedeo Smart

Independent Medical Education

Coomans de Brachene A, Castela A, Op de Beeck A, Mirmira RG, et al. Pre-clinical evaluation of TYK2 inhibitors for human beta cell protection in type 1 diabetes. Diabetes Obes Metab 2020 Jun 1. doi: 10.1111/dom.14104.
PMID: 32476252